Home / SUNPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SUNPHARMA.NS make money? Does SUNPHARMA.NS have pricing power? What's the Earnings Whisper? Will SUNPHARMA.NS profit more as the business scales? What is SUNPHARMA.NS's management track record? Is SUNPHARMA.NS's current price justified?

Sun Pharmaceutical Industries Limited

₹1758.8 +$37.70 (+2.19%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1764

Day Range

₹1743.5₹1764.9

Year Range

₹1583.7₹2046.9

Market Cap

4.22T

AVG Volume

1.9M

Trailing/Forward PE

34.89/27.21

PEG ratio

4.61

Dividend Yield

0.91%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

SUNPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	153B
26 Q4	146.12B
26 Q3	155.21B
26 Q2	144.78B
26 Q1	138.51B
25 Q4	129.59B
25 Q3	136.75B
25 Q2	132.91B
25 Q1	126.53B
24 Q4	119.83B

Net Income (INR) · Q

SUNPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	28.95B
26 Q4	27.14B
26 Q3	33.69B
26 Q2	31.18B
26 Q1	22.79B
25 Q4	21.5B
25 Q3	29.03B
25 Q2	30.4B
25 Q1	28.36B
24 Q4	26.55B

Operating Income (INR) · Q

SUNPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	35.57B
26 Q4	27.52B
26 Q3	40.62B
26 Q2	33.67B
26 Q1	33.72B
25 Q4	61.54B
25 Q3	75.58B
25 Q2	73.57B
25 Q1	67.47B
24 Q4	55.58B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Sun Pharmaceutical Industries Limited

Video analysis: SUNPHARMA.NS

News: SUNPHARMA.NS

Similar companies